raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:135

CACH syndrome

Synonyms: Childhood ataxia with diffuse central nervous system hypomyelination · Leukoencephalopathy with vanishing white matter · Myelinosis centralis diffusa

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Childhood
Status
active

A new leukoencephalopathy, the CACH syndrome (Childhood Ataxia with Central nervous system Hypomyelination) or VWM (Vanishing White Matter) was identified on clinical and MRI criteria. Classically, this disease is characterized by (1) an onset between 2 and 5 years of age, with a cerebello-spastic syndrome exacerbated by episodes of fever or head trauma leading to death after 5 to 10 years of disease evolution, (2) a diffuse involvement of the white matter on cerebral MRI with a CSF-like signal intensity (cavitation), (3) a recessive autosomal mode of inheritance, (4) neuropathologic findings consistent with a cavitating orthochromatic leukodystrophy with increased number of oligodendrocytes with sometimes ``foamy'' aspect.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enCACH syndromeChildhood ataxia with diffuse central nervous system hypomyelination · Leukoencephalopathy with vanishing white matter · Myelinosis centralis diffusa
frSyndrome CACHAtaxie infantile avec hypomyélinisation diffuse du système nerveux central · Leucoencéphalopathie avec perte de substance blanche · Myélinolyse centrale diffuse
deCACH-SyndromInfantile Ataxie mit diffuser Hypomyelinisierung des ZNS · Leukoenzephalopathie mit Verlust der weissen Hirnsubstanz · Myelinosis centralis diffusa
esSíndrome CACHAtaxia infantil con hipomielinización del sistema nervioso central · Leucoencefalopatía con desaparición de la sustancia blanca · Mielinosis central difusa
itSindrome CACHAtassia infantile con ipomielinizzazione diffusa del sistema nervoso centrale · Leucoencefalopatia con perdita della sostanza bianca · Mielinolisi centrale diffusa
nlCACH-syndroomAtaxie op kinderleeftijd met diffuse hypomyelinisatie van centraal zenuwstelsel · Leuko-encefalopathie met verdwijnende witte stof · Myelinosis centralis diffusa
ptSíndrome CACHAtaxia infantil com hipomielinização difusa do SNC · Leucoencefalopatia com desaparecimento de substância branca · Mielinose central difusa
plZespół CACHDziecięca ataksja z rozlaną hipomielinizacją centralnego układu nerwowego · Leukoencefalopatia z zanikającą istotą białą · Myelinosis centralis diffusa
csCACH syndromLeukoencefalopatie s mizející bílou hmotou · Myelinosis centralis diffusa · Dětská ataxie s difuzní hypomyelinizací centrálního nervového systému
ukCACH-синдромДитяча атаксія з дифузною гіпомієлінізацією центральної нервової системи · Лейкоенцефалопатія зі зникненням білої речовини · Центральний дифузний мієліноз
zhCACH综合征弥漫性中枢神经系统髓鞘形成减少伴儿童期共济失调
trCACH sendromuMyelinozis sentralis diffusa · Kaybolan beyaz cevher ile seyreden lökoensefalopati · Yaygın merkezi sinir sistemi hipomiyelinizasyon ile seyreden çocukluk çağı ataksisi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM603896Evalidated
OMIM615889BTNTvalidated
OMIM620312BTNTvalidated
OMIM620313BTNTvalidated
OMIM620314BTNTvalidated
OMIM620315BTNTvalidated
ICD-10E75.2NTBTattributedvalidated
ICD-118A44.3NTBTindexvalidated
MONDO0800448Evalidated
UMLSC1858991Evalidated
GARD231Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

Children (5):

4

Genes

0 direct · 26 via subtypes

Orphanet records no gene directly on this code.

Recorded by Orphanet on subtypes of this disorder:

GeneSubtypeAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
AARS2ORPHA:99853OvarioleukodystrophyDisease-causing germline mutation(s) (loss of function) inAssessedHGNC:21022ENSG000001246086120356p21.1alanyl-tRNA synthetase 2, mitochondrial24808023[PMID]
EIF2B1ORPHA:99853OvarioleukodystrophyDisease-causing germline mutation(s) inAssessedHGNC:3257ENSG0000011136160668612q24.31eukaryotic translation initiation factor 2B subunit alpha20301435[PMID]_15136673[PMID]
EIF2B1ORPHA:99854Cree leukoencephalopathyDisease-causing germline mutation(s) inAssessedHGNC:3257ENSG0000011136160668612q24.31eukaryotic translation initiation factor 2B subunit alpha20301435[PMID]_15136673[PMID]
EIF2B1ORPHA:157713Congenital or early infantile CACH syndromeDisease-causing germline mutation(s) inAssessedHGNC:3257ENSG0000011136160668612q24.31eukaryotic translation initiation factor 2B subunit alpha20301435[PMID]
EIF2B1ORPHA:157716Late infantile CACH syndromeDisease-causing germline mutation(s) inAssessedHGNC:3257ENSG0000011136160668612q24.31eukaryotic translation initiation factor 2B subunit alpha20301435[PMID]
EIF2B1ORPHA:157719Juvenile or adult CACH syndromeDisease-causing germline mutation(s) inAssessedHGNC:3257ENSG0000011136160668612q24.31eukaryotic translation initiation factor 2B subunit alpha20301435[PMID]
EIF2B2ORPHA:99853OvarioleukodystrophyDisease-causing germline mutation(s) inAssessedHGNC:3258ENSG0000011971860645414q24.3eukaryotic translation initiation factor 2B subunit beta20301435[PMID]_15136673[PMID]
EIF2B2ORPHA:99854Cree leukoencephalopathyDisease-causing germline mutation(s) inAssessedHGNC:3258ENSG0000011971860645414q24.3eukaryotic translation initiation factor 2B subunit beta20301435[PMID]_15136673[PMID]
EIF2B2ORPHA:157713Congenital or early infantile CACH syndromeDisease-causing germline mutation(s) inAssessedHGNC:3258ENSG0000011971860645414q24.3eukaryotic translation initiation factor 2B subunit beta20301435[PMID]
EIF2B2ORPHA:157716Late infantile CACH syndromeDisease-causing germline mutation(s) inAssessedHGNC:3258ENSG0000011971860645414q24.3eukaryotic translation initiation factor 2B subunit beta20301435[PMID]
EIF2B2ORPHA:157719Juvenile or adult CACH syndromeDisease-causing germline mutation(s) inAssessedHGNC:3258ENSG0000011971860645414q24.3eukaryotic translation initiation factor 2B subunit beta20301435[PMID]
EIF2B3ORPHA:99853OvarioleukodystrophyDisease-causing germline mutation(s) inAssessedHGNC:3259ENSG000000707856062731p34.1eukaryotic translation initiation factor 2B subunit gamma20301435[PMID]_15136673[PMID]
EIF2B3ORPHA:99854Cree leukoencephalopathyDisease-causing germline mutation(s) inAssessedHGNC:3259ENSG000000707856062731p34.1eukaryotic translation initiation factor 2B subunit gamma20301435[PMID]_15136673[PMID]
EIF2B3ORPHA:157713Congenital or early infantile CACH syndromeDisease-causing germline mutation(s) inAssessedHGNC:3259ENSG000000707856062731p34.1eukaryotic translation initiation factor 2B subunit gamma20301435[PMID]
EIF2B3ORPHA:157716Late infantile CACH syndromeDisease-causing germline mutation(s) inAssessedHGNC:3259ENSG000000707856062731p34.1eukaryotic translation initiation factor 2B subunit gamma20301435[PMID]
EIF2B3ORPHA:157719Juvenile or adult CACH syndromeDisease-causing germline mutation(s) inAssessedHGNC:3259ENSG000000707856062731p34.1eukaryotic translation initiation factor 2B subunit gamma20301435[PMID]
EIF2B4ORPHA:99853OvarioleukodystrophyDisease-causing germline mutation(s) inAssessedHGNC:3260ENSG000001152116066872p23.3eukaryotic translation initiation factor 2B subunit delta20301435[PMID]_15136673[PMID]
EIF2B4ORPHA:99854Cree leukoencephalopathyDisease-causing germline mutation(s) inAssessedHGNC:3260ENSG000001152116066872p23.3eukaryotic translation initiation factor 2B subunit delta20301435[PMID]_15136673[PMID]
EIF2B4ORPHA:157713Congenital or early infantile CACH syndromeDisease-causing germline mutation(s) inAssessedHGNC:3260ENSG000001152116066872p23.3eukaryotic translation initiation factor 2B subunit delta20301435[PMID]
EIF2B4ORPHA:157716Late infantile CACH syndromeDisease-causing germline mutation(s) inAssessedHGNC:3260ENSG000001152116066872p23.3eukaryotic translation initiation factor 2B subunit delta20301435[PMID]
EIF2B4ORPHA:157719Juvenile or adult CACH syndromeDisease-causing germline mutation(s) inAssessedHGNC:3260ENSG000001152116066872p23.3eukaryotic translation initiation factor 2B subunit delta20301435[PMID]
EIF2B5ORPHA:99853OvarioleukodystrophyDisease-causing germline mutation(s) inAssessedHGNC:3261ENSG000001451916039453q27.1eukaryotic translation initiation factor 2B subunit epsilon20301435[PMID]_15136673[PMID]
EIF2B5ORPHA:99854Cree leukoencephalopathyDisease-causing germline mutation(s) inAssessedHGNC:3261ENSG000001451916039453q27.1eukaryotic translation initiation factor 2B subunit epsilon20301435[PMID]_15136673[PMID]
EIF2B5ORPHA:157713Congenital or early infantile CACH syndromeDisease-causing germline mutation(s) inAssessedHGNC:3261ENSG000001451916039453q27.1eukaryotic translation initiation factor 2B subunit epsilon20301435[PMID]
EIF2B5ORPHA:157716Late infantile CACH syndromeDisease-causing germline mutation(s) inAssessedHGNC:3261ENSG000001451916039453q27.1eukaryotic translation initiation factor 2B subunit epsilon20301435[PMID]
EIF2B5ORPHA:157719Juvenile or adult CACH syndromeDisease-causing germline mutation(s) inAssessedHGNC:3261ENSG000001451916039453q27.1eukaryotic translation initiation factor 2B subunit epsilon20301435[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families148 casesWorldwideCase(s)ValidatedORPHANET
Point prevalenceUnknown—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

55 annotations · validated 2020-12-18
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0410263Brain imaging abnormality
HP:0006978Dysmyelinating leukodystrophy
Frequent (79-30%)
HP:0007366Atrophy/Degeneration affecting the brainstem
HP:0001272Cerebellar atrophy
HP:0006855Cerebellar vermis atrophy
HP:0002059Cerebral atrophy
HP:0001347Hyperreflexia
HP:0000737Irritability
HP:0002070Limb ataxia
HP:0000648Optic atrophy
HP:0008209Premature ovarian insufficiency
HP:0002344Progressive neurologic deterioration
HP:0001250Seizure
HP:0001257Spasticity
HP:0002078Truncal ataxia
Occasional (29-5%)
HP:0007361Abnormality of the pons
HP:0000741Apathy
HP:0002804Arthrogryposis multiplex congenita
HP:0000708Atypical behavior
HP:0000618Blindness
HP:0000518Cataract
HP:0100543Cognitive impairment
HP:0001558Decreased fetal movement
HP:0001260Dysarthria
HP:0032398Dysgyria
HP:0001310Dysmetria
HP:0002015Dysphagia
HP:0001298Encephalopathy
HP:0011968Feeding difficulties
HP:0001371Flexion contracture
HP:0008947Floppy infant
HP:0033049Globus pallidus hypointensity on susceptibility-weighted imaging
HP:0000133Gonadal dysgenesis
HP:0001510Growth delay
HP:0002315Headache
HP:0001269Hemiparesis
HP:0001433Hepatosplenomegaly
HP:0001511Intrauterine growth retardation
HP:0006956Lateral ventricle dilatation
HP:0000252Microcephaly
HP:0002076Migraine
HP:0011342Mild global developmental delay
HP:0001270Motor delay
HP:0008288Nonketotic hyperglycinemia
HP:0001562Oligohydramnios
HP:0100653Optic neuritis
HP:0001733Pancreatitis
HP:0000786Primary amenorrhea
HP:0000089Renal hypoplasia
HP:0000869Secondary amenorrhea
HP:0001264Spastic diplegia
HP:0012690T2 hypointense thalamus
HP:0002013Vomiting
HP:0012704Widened subarachnoid space
Very rare (<4-1%)
HP:0004481Progressive macrocephaly

Run the differential on the 2 obligate / very frequent terms

Annotation source: 29740943[PMID]_20301435[PMID]

7

Sources for this card